Skip to content
Home
About us
Insights
Stocks
Compliance
Special Services
Contact
Language
EN
BR
EN
EN
BR
Tag:
Anvisa
Insights
Anvisa Approves EMS’s Ozivy, Brazil’s First Semaglutide Pen
26 de May de 2026
Insights
Anvisa aprova Ozivy, da EMS, primeira caneta semaglutida brasileira
26 de May de 2026
Insights
Anvisa Reviews Elevidys, a R$20 Million Gene Therapy Suspended in Brazil
29 de April de 2026
Insights
Anvisa reavalia Elevidys, terapia de R$20 milhões suspensa no Brasil
29 de April de 2026
Behind the Lines
O remédio que está secando o consumo
15 de April de 2026
Behind the Lines
The drug that is drying up consumption
15 de April de 2026
Nelson Mussolini
,
Opinion
When State Failure Becomes a Public Health Risk
31 de March de 2026
Insights
Lula Expands India Trip With Pharma Fast-Track and Defense Push
17 de February de 2026
Insights
Pharma Groups Warn Congress Over Broader Compulsory Licensing
11 de February de 2026
Insights
Brazil’s Anvisa Expands Medical Cannabis Rules, Allows Compounding Pharmacies
28 de January de 2026
